Pantocid I.V. Injection is used to treat severe gastroesophageal reflux disease (GERD), active peptic ulcers, and acute hypersecretory conditions under clinical settings. It serves as a vital clinical alternative for patients with bleeding ulcers or those unable to take oral medicines due to surgery. It helps restabilise gastric equilibrium rapidly, ensuring patient comfort during critical care phases.
It contains Pantoprazole Sodium as its active ingredients, which functions as a potent proton pump inhibitor (PPI). When delivered intravenously, it works by directly shutting down the acid-secreting proton pumps located within the gastric parietal cells. This immediate action sharply lowers total acid volume, halting further mucosal layer erosion.
This medication provides a highly protective internal environment that accelerates the natural healing of damaged esophageal and stomach tissues. The treatment is intended for short-term management until a transition to oral tablets is medically feasible. The dosage must be administered by a healthcare professional as prescribed by your doctor.


























































